Josephine Wesely

New York Stem Cell Foundation — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

5h-index233citations14works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(3), Acute Myeloid Leukemia Research(3), Pluripotent Stem Cells Research(3), Peptidase Inhibition and Analysis(3), CRISPR and Genetic Engineering(2)

Publications14 total

Generation of a male isogenic pair and a female isogenic pair(R83C) for studying NAA10-related syndrome as part of a large Ogden syndrome biobank
Stem Cell Research·2026Open Access
A repository of Ogden syndrome patient derived iPSC lines and isogenic pairs by X-chromosome screening and genome-editing
2024· 1 citedOpen Access
P238: Discovery of the phenotypic landscape and mechanistic understanding of NAA10-related and NAA15-related neurodevelopmental syndromes, using mouse models and iPSCs*
Genetics in Medicine Open·2023Open Access
PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1
Oncogenesis·2021· 42 citedOpen Access
Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells
Cell Reports·2020· 47 citedOpen Access
Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of leukemia
2020· 1 citedOpen Access
A Novel iPSC Model Reveals a Role for RUNX1 in the Maintenance of AML Leukemia Stem Cells
Blood·2018
The role of FUBP1 in hematopoietic stem cells and during erythroid maturation
Experimental Hematology·2017
Delayed Mesoderm and Erythroid Differentiation of Murine Embryonic Stem Cells in the Absence of the Transcriptional Regulator FUBP1
Stem Cells International·2017· 6 citedOpen Access
Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma
European Journal of Cancer·2016
Abstract B39: Inhibition of the oncoprotein FUBP1 by SN-38 represents a novel therapeutic option for the treatment of hepatocellular carcinoma
Cancer Research·2016
FAM96A is a novel pro-apoptotic tumor suppressor in gastrointestinal stromal tumors
International Journal of Cancer·2015· 28 citedOpen Access
EEF1A2 Inactivates p53 by Way of PI3K/AKT/mTOR-Dependent Stabilization of MDM4 in Hepatocellular Carcinoma
Hepatology·2013· 104 citedOpen Access
Influence of seasonal biorhythms on urinary excretion of enzymes and other parameters.
PubMed·1990· 4 cited

Frequent Co-authors

Martin Zörnig(6), Andriana G. Kotini(3), Han Yuan(3), Christina S. Leslie(3), Eirini P. Papapetrou(3), Frederick J. Monsma(3), Franco Izzo(2), Hanzhi Luo(2), Maria Georgomanoli(2), Dan A. Landau(2), Michael G. Kharas(2), Marlene Steiner(2), Michael A. Rieger(2), Tom Rusielewicz(2), Elaine Marchi(2), Manali Nikte(2), Dorota Moroziewicz(2), Lauren Bauer(2), Daniel Paull(2), Gholson J. Lyon(2)